Dogwood Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DWTX | MDNA.TO | ABVC | HOWL | 18H0.F | JSPR | |
|---|---|---|---|---|---|---|
| Market cap | 39.37M | 40.15M | 26.69M | 52.98M | 5.11M | 17.01M |
| P/E (TTM) | 0.5 | — | — | — | — | — |
| Forward P/E | -0.2 | -1.9 | -2.3 | -1.8 | — | -0.7 |
| Price/book | 0.5 | 24.2 | 2.5 | 3.3 | -1.1 | 10.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −80.19% | −70.81% | −64.79% | −9.17% | −25.00% | −72.08% |
| Today | −0.96% | +4.82% | +1.51% | +1.87% | −23.81% | +6.48% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DWTX news ›Dogwood Therapeutics, Inc (NASDAQ:DWTX) Stock Short Interest Climbs 60.4%
Posted by Sarita Garza on Nov 2nd, 2026 Dogwood Therapeutics (NASDAQ:DWTX – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of…
Dogwood Therapeutics to sell 4.1M shares at $1.22
Dogwood Therapeutics (DWTX) is a development-stage biopharmaceutical company developing non-opioid pain and neuropathy medicines, led by Halneuron and SP16 IV. - [SCHEDULE 13D/A] Dogwood Therapeutics, Inc. Amended Major Shareholder Report…
Dogwood Therapeutics secures $5M investment from largest shareholder; shares rise
Dogwood Therapeutics (DWTX) secures $5M private placement at $1.22/share to fund Halneuron Phase 3 prep and extend runway to March 2027—read now. Dogwood Therapeutics (DWTX) has secured a $5M investment from a subsidiary of CK Life…
Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
--Dogwood Therapeutics, Inc., a company that focuses on developing first-in-class, new non-opioid medicines to treat pain and neuropathy, today announced that the Company has entered into a securities subscription agreement for a $5…
Dogwood to Participate in the 2026 Maxim Growth Summit
The Manila Times Dogwood to Participate in the 2026 Maxim Growth Summit ATLANTA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company”), a company that focuses on developing first-in-class, new…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- stocktitan.net2
- themarketsdaily.com2
- manilatimes.net1
- quiverquant.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.